Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis
- PMID: 19631279
- DOI: 10.1016/j.micinf.2009.07.004
Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis
Abstract
We used various genotyping methods to identify bacterial genetic markers for development of arthritic symptoms following Campylobacter enteritis. We genotyped a collection of population derived Campylobacter strains, with detailed information on clinical characteristics, including arthritic symptoms. Besides using whole genome screening methods, we focused on the lipo-oligosaccharide (LOS) gene locus in which marker genes for developing post-Campylobacter neurological disease are present. Patients with arthritic symptoms were more frequently infected with Campylobacter jejuni strains with a class A LOS locus. We also found that patients who were infected with a C. jejuni strain containing sialic acid-positive LOS (class A, B or C) more frequently had bloody diarrhoea and a longer duration of symptoms. Furthermore, the IgM antibody response against Campylobacter was stronger in patients with a sialic acid containing LOS. Ganglioside auto-antibodies were observed in a small number of patients following infection with a class C strain. We conclude that sialylation of C. jejuni LOS is not only a risk factor for development of post-infectious symptoms, but is also associated with increased severity of enteric disease.
Similar articles
-
Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.J Infect Dis. 2006 Feb 15;193(4):547-55. doi: 10.1086/499969. Epub 2006 Jan 19. J Infect Dis. 2006. PMID: 16425134
-
Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.PLoS One. 2012;7(3):e34416. doi: 10.1371/journal.pone.0034416. Epub 2012 Mar 28. PLoS One. 2012. PMID: 22470569 Free PMC article.
-
Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.Int J Med Microbiol. 2013 Apr;303(3):134-9. doi: 10.1016/j.ijmm.2013.01.005. Epub 2013 Mar 6. Int J Med Microbiol. 2013. PMID: 23528202
-
Acute postinfectious glomerulonephritis associated with Campylobacter jejuni enteritis - a case report and review of the literature on C. jejuni's potential to trigger immunologically mediated renal disease.Clin Nephrol. 2010 Dec;74(6):474-9. Clin Nephrol. 2010. PMID: 21084052 Review.
-
The pathogenesis of Campylobacter jejuni-mediated enteritis.Curr Issues Intest Microbiol. 2001 Sep;2(2):55-71. Curr Issues Intest Microbiol. 2001. PMID: 11721281 Review.
Cited by
-
Epidemiological association of Campylobacter jejuni groups with pathogenicity-associated genetic markers.BMC Microbiol. 2012 Aug 8;12:171. doi: 10.1186/1471-2180-12-171. BMC Microbiol. 2012. PMID: 22873291 Free PMC article.
-
Biological functions of sialic acid as a component of bacterial endotoxin.Front Microbiol. 2022 Oct 20;13:1028796. doi: 10.3389/fmicb.2022.1028796. eCollection 2022. Front Microbiol. 2022. PMID: 36338080 Free PMC article. Review.
-
Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice.Microorganisms. 2022 Sep 30;10(10):1953. doi: 10.3390/microorganisms10101953. Microorganisms. 2022. PMID: 36296229 Free PMC article.
-
Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.Front Cell Infect Microbiol. 2012 Feb 14;2:9. doi: 10.3389/fcimb.2012.00009. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22919601 Free PMC article. Review.
-
Oral curcumin ameliorates acute murine campylobacteriosis.Front Immunol. 2024 May 24;15:1363457. doi: 10.3389/fimmu.2024.1363457. eCollection 2024. Front Immunol. 2024. PMID: 38855111 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical